Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP
Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie
Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie
View: Text | PDF
Research Article Muscle biology

Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP

  • Text
  • PDF
Abstract

Skeletal muscle wasting results from numerous pathological conditions affecting both the musculoskeletal and nervous systems. A unifying feature of these pathologies is the upregulation of members of the E3 ubiquitin ligase family, resulting in increased proteolytic degradation of target proteins. Despite the critical role of E3 ubiquitin ligases in regulating muscle mass, the specific proteins they target for degradation and the mechanisms by which they regulate skeletal muscle homeostasis remain ill-defined. Here, using zebrafish loss-of-function models combined with in vivo cell biology and proteomic approaches, we reveal a role of atrogin-1 in regulating the levels of the endoplasmic reticulum chaperone BiP. Loss of atrogin-1 resulted in an accumulation of BiP, leading to impaired mitochondrial dynamics and a subsequent loss in muscle fiber integrity. We further implicated a disruption in atrogin-1–mediated BiP regulation in the pathogenesis of Duchenne muscular dystrophy. We revealed that BiP was not only upregulated in Duchenne muscular dystrophy, but its inhibition using pharmacological strategies, or by upregulating atrogin-1, significantly ameliorated pathology in a zebrafish model of Duchenne muscular dystrophy. Collectively, our data implicate atrogin-1 and BiP in the pathogenesis of Duchenne muscular dystrophy and highlight atrogin-1’s essential role in maintaining muscle homeostasis.

Authors

Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie

×

Figure 6

Atrogin-1 is a modifier of and contributes to the pathogenesis of Duchenne muscular dystrophy.

Options: View larger image (or click on image) Download as PowerPoint
Atrogin-1 is a modifier of and contributes to the pathogenesis of Duchen...
(A) Representative Western blot image for BiP, and total protein direct blue stain, on whole cell protein lysates obtained from 2 dpf and 4 dpf dmd+/+ or dmd–/– larvae. (B) Quantification of BiP levels normalized to total protein with 4 dpf dmd–/– larvae displaying a significant increase compared with dmd+/+ larvae, as determined using a 2-way ANOVA with Šidák’s multiple correction post hoc test. Data are shown as mean ± SD. (C–F) Representative birefringence images of 4 dpf dmd+/+; atrogin-1+/+ wild-type larvae and dmd–/– and atrogin-1–/– single and double mutants. Scale bar: 500 μm. (G) Quantification of normalized birefringence intensity, which is the mean birefringence intensity relative to area, in 4 dpf dmd+/+; atrogin-1+/+ wild-type larvae and dmd–/– and atrogin-1–/– single and double mutants, analyzed using a 1-way ANOVA with Tukey’s multiple correction post hoc test. Data are shown as mean ± SD. (H) Average speed, in mm/s, of dmd+/+; atrogin-1+/+ wild-type larvae and dmd–/– and atrogin-1–/– single and double mutants, as analyzed using as a 1-way ANOVA with Tukey’s multiple correction post hoc test. Data are shown as mean ± SEM for 3–4 biological replicates. (I and J) Live images of 4 dpf larvae expressing GFP RNA or atrogin-1-IRES-GFP RNA. Scale bar: 200 μm. (K–N) Birefringence images of 4 dpf dmd+/+ and dmd–/– larvae injected with GFP RNA or atrogin-1-IRES-GFP RNA. Scale bar: 500 μm. (O) Quantification of normalized birefringence intensity, which is the mean birefringence intensity relative to area, in 4 dpf dmd+/+ or dmd–/– larvae injected with GFP RNA or atrogin-1-IRES-GFP RNA, as analyzed using a 2-way ANOVA with Šidák’s multiple correction post hoc test. Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All experiments performed in triplicate with the total number of fish examined in each replicate being documented in Supplemental Table 2.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts